Russian President, Vladimir Putin, in a televised conference yesterday said that a Russian vaccine for the novel coronavirus was approved “for the first time in the world.” The vaccine which has been approved for regulation after less than two months of testing on humans, caused a lot of concern among health officials the world over. The concern being that safety and proper testing has been sidelined for the sake of a political statement.
Putin assured the public that the vaccine passed the testing criteria, “I would like to repeat that it has passed all the necessary tests. The most important thing is to ensure full safety of using the vaccine and its efficiency.” Putin added that the vaccine developed by Moscow’s Gamaleya Institute would provide “sustainable immunity” against the virus.
Russian vaccine approved says Putin
To drive the point home, Putin said that the vaccine had been administered to one of his own daughters, “One of my daughters got vaccinated, so in this sense, she took part in the testing.” Elaborating further he explained that she became well after two shots of the vaccine, “After the first injection her temperature was 38 degrees, the next day 37.5, and that was it. After the second injection her temperature went up slightly, then back to normal. She is feeling well and has a high antibody count.”
Putin did not say which of his daughters got inoculated, it is rare enough for the president to mention them. His daughters named Maria Vorontsova who is a medical researcher, and Katerina Tikhonova who is an accomplished aerobics dancer, according to news reports, have lived their lives under false identities to conceal their family backgrounds. President Putin is secretive about his family as he feels he needs to protect them.
Health authorities have said that medical workers, teachers and other risk groups will be the first to get vaccinated. The Russian vaccine reportedly uses adapted strains of the adenovirus, a virus that usually causes the common cold, to trigger an immune response. Health officials in America worry that this would fuel an urgency for President Donald Trump to rush a vaccine. The Russian health authorities do not have as rigorous a testing criteria as its counterparts in other countries. Two pharmaceutical companies have moved to phase three testing in the United States.